Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | Director | August 23, 2018 | August 24, 2018 |
| Nielsen Holdings plcNLSN · Entity 16431 | Director | March 31, 2021 | April 01, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date August 23, 2018 · Filed August 24, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 62,369 |
Reported balance
After 2018-08-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-08-23 · Exercise / conversion · Acquired 2,671 · Balance 62,369 F1: This balance increased 155 shares due to exempt transactions such as dividend reinvestment. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 64,182 |
Reported balance
After 2018-08-23 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-08-23 · Exercise / conversion · Acquired 1,813 · Balance 64,182 |
| Ordinary SharesSEC Table I · non-derivative | Direct | 60,964 |
Reported balance
After 2018-08-23 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-08-23 · Sale · Disposed 3,218 · Balance 60,964 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.96 · Expires 2019-04-27 | Direct | 0 |
Reported balance
After 2018-08-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-08-23 · Exercise / conversion · Disposed 2,671 · Balance 0 F2: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.13 · Expires 2020-05-03 | Direct | 0 |
Reported balance
After 2018-08-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-08-23 · Exercise / conversion · Disposed 1,813 · Balance 0 F3: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. |
Filing footnotes · ownership attribution and instrument terms
F1: This balance increased 155 shares due to exempt transactions such as dividend reinvestment.
F2: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F3: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
Nielsen Holdings plc
Report date March 31, 2021 · Filed April 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 247,580.901 |
Reported balance
After 2021-03-31 transaction · row 1
1 source rowRow 1 · 2021-03-31 · Grant · Acquired 944.33 · Balance 247,580.901 F1: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 31, 2021 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 31, 2021 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2021 Filed Apr 1, 2021 21:36 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 944.33 | $25.15 | $23,749.90 |
DisclosureSEC source: 0001209191-21-024322 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,580.901 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 31, 2021 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 18:32 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 151.775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022423 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,636.571 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:41 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 228.278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-062035 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,484.796 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 18:06 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 255.222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049776 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,256.518 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 16:29 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 258.76 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038190 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,001.296 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| May 01, 2020 Filed May 5, 2020 18:43 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 9,742.12 | $13.96 | $136,000.00 |
DisclosureSEC source: 0001209191-20-027286 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,023.336 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of May 1, 2020. The deferred stock units each represent one share of Nielsen common stock and vest in four substantially equal installments on each of August 1, 2020, November 1, 2020, February 1, 2021 and May 1, 2021, except that each of Nielsen's independent directors has agreed to reduce his or her total annual director compensation by 30% for the second and third quarters of 2020. Therefore, the amounts vesting in August and November 2020 have been reduced by 30%, and the total amount of deferred stock units reported as issued in Table I reflects such reduction. Read SEC document |
| May 01, 2020 Filed May 8, 2020 21:02 UTC Amendment | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 11,461.32 | $13.96 | $160,000.03 |
DisclosureSEC source: 0001209191-20-028123 · doc4a.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,742.536 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of May 1, 2020. The deferred stock units each represent one share of Nielsen common stock and vest in four substantially equal installments on each of August 1, 2020, November 1, 2020, February 1, 2021 and May 1, 2021. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:01 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 211.648 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020772 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,281.216 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 16:17 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 1,169.95 | $20.30 | $23,749.99 |
DisclosureSEC source: 0001209191-20-000908 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,069.568 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of December 31, 2019 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 18:53 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 158.448 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-059530 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,899.618 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 16:23 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 1,117.65 | $21.25 | $23,750.06 |
DisclosureSEC source: 0001209191-19-051680 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,741.17 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of September 30, 2019 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 06:24 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 834.624 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-048834 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,623.52 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| July 01, 2019 Filed Jul 1, 2019 16:26 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 1,050.88 | $22.60 | $23,749.89 |
DisclosureSEC source: 0001209191-19-039720 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,788.896 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of June 28, 2019 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 21:24 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 717.157 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038346 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,738.016 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| May 01, 2019 Filed May 3, 2019 17:19 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 6,436.04 | $24.86 | $159,999.95 |
DisclosureSEC source: 0001209191-19-027464 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,020.859 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of May 1, 2019. The deferred stock units each represent one share of Nielsen common stock and vest in four substantially equal installments on each of August 1, 2019, November 1, 2019, February 1, 2020 and May 1, 2020. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 17:18 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 1,003.38 | $23.67 | $23,750.00 |
DisclosureSEC source: 0001209191-19-022037 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,584.819 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 29, 2019 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| March 21, 2019 Filed Mar 25, 2019 17:00 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 515.702 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021184 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,581.439 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 19:00 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 1,018 | $23.33 | $23,749.94 |
DisclosureSEC source: 0000899243-19-000167 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,065.737 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of December 31, 2018 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| December 05, 2018 Filed Dec 7, 2018 16:24 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 502.526 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061493 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,047.737 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 16:35 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 858.64 | $27.66 | $23,749.98 |
DisclosureSEC source: 0001209191-18-053184 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,545.211 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of September 28, 2018 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 16:46 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 498.048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-050090 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,686.571 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:32 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,813 | $0.00 Strike: $44.13 | $0.00 |
DisclosureSEC source: 0001127602-18-026214 · form4.xml · derivative · entry 5 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,813 shares Expires 2020-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:32 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,671 | $0.00 Strike: $29.96 | $0.00 |
DisclosureSEC source: 0001127602-18-026214 · form4.xml · derivative · entry 4 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,671 shares Expires 2019-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:32 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 3,218 | $95.94 | $308,738.14 |
DisclosureSEC source: 0001127602-18-026214 · form4.xml · nonDerivative · entry 3 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,964 Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:32 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,813 | $44.13 | $80,007.69 |
DisclosureSEC source: 0001127602-18-026214 · form4.xml · nonDerivative · entry 2 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:32 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 2,671 | $29.96 | $80,023.16 |
DisclosureSEC source: 0001127602-18-026214 · form4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance increased 155 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 16:15 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 767.86 | $30.93 | $23,749.91 |
DisclosureSEC source: 0000899243-18-019181 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,188.523 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of June 29, 2018 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 16:12 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 413.791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039170 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,420.663 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 16:37 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 11,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-020796 · form4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,543 Read SEC document |
| May 01, 2018 Filed May 2, 2018 14:59 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015916 · form4.xml · nonDerivative · entry 2 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,167 Read SEC document |
| May 01, 2018 Filed May 3, 2018 16:10 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 5,204.94 | $30.74 | $159,999.86 |
DisclosureSEC source: 0001209191-18-027586 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,006.872 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of May 1, 2018. The deferred stock units each represent one share of Nielsen common stock and vest in four substantially equal installments on each of August 1, 2018, November 1, 2018, February 1, 2019 and May 1, 2019. Read SEC document |
| April 30, 2018 Filed May 2, 2018 14:59 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015916 · form4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,783 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased 613 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:04 UTC | Nielsen Holdings plc NLSN · Entity 16431 | Exercise / conversionOptions to Purchase Common Stock (right to buy) · Derivative | 12,210 | $0.00 Strike: $29.83 | $0.00 |
DisclosureSEC source: 0001209191-18-027058 · doc4.xml · derivative · entry 3 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,210 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options to purchase shares of common stock are currently vested and are exercisable. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:04 UTC | Nielsen Holdings plc NLSN · Entity 16431 | SaleCommon Stock | 12,210 | $31.96 | $390,207.18 |
DisclosureSEC source: 0001209191-18-027058 · doc4.xml · nonDerivative · entry 2 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,801.932 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.94 to $32.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:04 UTC | Nielsen Holdings plc NLSN · Entity 16431 | Exercise / conversionCommon Stock | 12,210 | $29.83 | $364,224.30 |
DisclosureSEC source: 0001209191-18-027058 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,011.932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2018 Filed Apr 2, 2018 16:23 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 747.09 | $31.79 | $23,749.99 |
DisclosureSEC source: 0001209191-18-022374 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,801.932 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 29, 2018 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 16:20 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 315.217 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021397 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,054.842 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| January 02, 2018 Filed Jan 2, 2018 16:21 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 652.47 | $36.40 | $23,749.91 |
DisclosureSEC source: 0001209191-18-000199 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,739.625 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of December 29, 2017 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| December 05, 2017 Filed Dec 6, 2017 16:57 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 262.092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064209 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,087.155 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 17:44 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 572.98 | $41.45 | $23,750.02 |
DisclosureSEC source: 0001209191-17-055334 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,825.063 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of September 29, 2017 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 16:44 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 249.93 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-052064 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,211.91 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 15:44 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 614.33 | $38.66 | $23,750.00 |
DisclosureSEC source: 0001209191-17-043161 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,961.98 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of June 30, 2017 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 09:45 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 243.632 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040996 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,347.65 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 17:48 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 628 | $87.65 | $55,044.20 |
DisclosureSEC source: 0001127602-17-021523 · form4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,987 Read SEC document |
| May 01, 2017 Filed May 3, 2017 15:33 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 3,947.69 | $40.53 | $159,999.88 |
DisclosureSEC source: 0001209191-17-029569 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,104.018 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of May 1, 2017. The deferred stock units each represent one share of Nielsen common stock and vest in four substantially equal installments on each of August 1, 2017, November 1, 2017, February 1, 2018 and May 1, 2018. Read SEC document |
| May 01, 2017 Filed May 3, 2017 16:08 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016611 · form4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,615 F1 · security: This balance increased by 302 shares due to exempt transactions such as dividend reinvestment. F2 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 15:42 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 574.92 | $41.31 | $23,749.95 |
DisclosureSEC source: 0001209191-17-024101 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,156.328 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of March 31, 2017 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| March 16, 2017 Filed Mar 21, 2017 21:07 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 160.546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022156 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,581.408 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 13:02 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 566.15 | $41.95 | $23,749.99 |
DisclosureSEC source: 0001209191-17-000652 · doc4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,420.862 F1 · kind: Represents deferred stock units issued to the Reporting Person at the closing trading price as of December 30, 2016 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of December 30, 2016 in lieu of cash compensation pursuant to the terms of the Directors Deferred Compensation Plan (the "Plan"). Each deferred stock unit represents one share of Nielsen common stock and is fully vested. The shares subject to the units will be issued to the Reporting Person at a future date in accordance with the terms of the Plan, and the Reporting Person's plan election. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 15:57 UTC | Medtronic plc MDT · Entity 2888 | PurchaseOrdinary Shares | 13,660 | $73.21 | $999,983.03 |
DisclosureSEC source: 0001127602-16-069999 · form4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,223 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $73.13 to $73.25, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. F2 · balance_after: This balance increased by 137 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.